HomeSABSW • NASDAQ
add
SAB Biotherapeutics
Previous close
$0.028
Day range
$0.026 - $0.034
Year range
$0.021 - $0.15
Market cap
31.29M USD
Avg Volume
16.96K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.74M | -24.91% |
Net income | -10.11M | -37.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.96M | 2.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.71M | -84.69% |
Total assets | 30.13M | -51.32% |
Total liabilities | 18.11M | 14.84% |
Total equity | 12.02M | — |
Shares outstanding | 10.41M | — |
Price to book | 0.02 | — |
Return on assets | -71.30% | — |
Return on capital | -104.36% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -10.11M | -37.88% |
Cash from operations | -7.15M | 7.34% |
Cash from investing | 5.20M | -53.67% |
Cash from financing | -173.84K | 45.85% |
Net change in cash | -1.95M | -160.72% |
Free cash flow | -3.73M | 19.62% |
About
Founded
2014
Headquarters
Website
Employees
63
